Skip to main content

Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study.

Publication ,  Journal Article
Demark-Wahnefried, W; Kenyon, AJ; Eberle, P; Skye, A; Kraus, WE
Published in: Clin Exerc Physiol
February 2002

PURPOSE: Weight gain is a common side effect of adjuvant chemotherapy for breast cancer - a side effect that decreases quality of life and also may decrease both disease-free and overall survival. This weight gain also is unique, since patients lose lean body mass while they gain weight. These body composition changes become apparent within six months of diagnosis. METHODS: We explored whether a clinic-based exercise program, which promoted a specialized program of strength training, aerobic activity and a healthful (

Duke Scholars

Published In

Clin Exerc Physiol

ISSN

1520-8702

Publication Date

February 2002

Volume

4

Issue

1

Start / End Page

44 / 49

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Demark-Wahnefried, W., Kenyon, A. J., Eberle, P., Skye, A., & Kraus, W. E. (2002). Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol, 4(1), 44–49.
Demark-Wahnefried, Wendy, Anne Jacobs Kenyon, Pamela Eberle, Ann Skye, and William E. Kraus. “Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study.Clin Exerc Physiol 4, no. 1 (February 2002): 44–49.
Demark-Wahnefried W, Kenyon AJ, Eberle P, Skye A, Kraus WE. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol. 2002 Feb;4(1):44–9.
Demark-Wahnefried, Wendy, et al. “Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study.Clin Exerc Physiol, vol. 4, no. 1, Feb. 2002, pp. 44–49.
Demark-Wahnefried W, Kenyon AJ, Eberle P, Skye A, Kraus WE. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol. 2002 Feb;4(1):44–49.

Published In

Clin Exerc Physiol

ISSN

1520-8702

Publication Date

February 2002

Volume

4

Issue

1

Start / End Page

44 / 49

Location

United States